EU Liaison To CIR Among Changes Planned To Strengthen Panel
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic Ingredient Review Expert Panel plans to add a representative from the European Union as part of a program designed to strengthen the CIR process. The EU liaison is expected to improve communication regarding international harmonization and help FDA to implement the harmonization requirements of the FDA Modernization Act.